Angiogenesis inhibitors in cancer therapeutics

In the era molecular pharmacology, development of angiogenesis inhibitors is certainly a master discovery .There are specific angiogenesis inhibitors are being used in cancer and various endogenous anti-angiogenesis molecules are discovered .This review is a coverage of basic anti-angiogenic molecule like bevacizumab and other newer targets, after explaining the basic physiology of new vessel formation which helps in better understanding of these drugs. [Int J Basic Clin Pharmacol 2014; 3(1.000): 24-26]